Chief Healthcare Executive October 9, 2023
LaVarne Burton, Hrant Jamgochian, Lori Hartwell

The Centers for Medicare & Medicaid Services’ latest proposed rule regarding Medicare reimbursement for dialysis has missed an opportunity to support the kidney community.

In recent years, lawmakers have turned their attention to advancing racial equity and creating opportunities for the improvement of historically underserved communities – and rightly so.

The urgent need for such improvements is dramatically apparent for people who have end-stage renal disease (ESRD), or kidney failure. While people of all races and ethnicities develop chronic kidney disease (CKD) at similar rates, ESRD disproportionately impacts people of color.

Black Americans make up 13% of the U.S. population, but the disparities are evident when one considers that they account for 35% of Americans with kidney failure and are...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medicare, Provider
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Prior authorizations, pharmacy transparency, vertical integration all part of the Medicare 2026 rule
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article